David Raben, Chief Medical Officer at Bicara Therapeutics Inc. (BCAX), sold 5,500 shares at $22.88 ($126K) on 2026-04-27, disclosed to the SEC on 2026-04-28.
Scheduled sale ($126k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BCAX | SELL | 2025-11-25 | $292K | — | Filing → |
| BCAX | SELL | 2025-10-10 | $406K | — | Filing → |